• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SPL

STARPHARMA HOLDINGS LIMITED

0.00% ! 9.4¢
Market Cap $39.31M  !

Starpharma Holdings Limited is an Australia-based biotechnology company. The principal... Starpharma Holdings Limited is an Australia-based biotechnology company. The principal activities of the Company consist of research, development and commercialization of dendrimer products for pharmaceutical and healthcare applications. Its portfolio of dendrimer-based products includes three clinical-stage DEP (dendrimer enhanced product) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over-the-counter (OTC) products. It has developed a pipeline of novel DEP oncology products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, it has a preclinical pipeline of DEP radiopharmaceuticals and DEP Antibody-Drug Conjugates (ADCs) in development. Its VIRALEZE Nasal Spray is a broad-spectrum nasal spray intended to provide a protective barrier in the nose that traps and blocks cold/respiratory viruses. It also offers VivaGel BV and VivaGel Condom products. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SPL
2024/25 Achievements
14:28 4 1.1K
14:28 Last post  sarge17 Comments Created with Sketch.  4  Views Created with Sketch.  1.1K 
SPL
Assessment of Viraleze revenue from online sales
11:12 23 5.6K
11:12 Last post  Teddyward Comments Created with Sketch.  23  Views Created with Sketch.  5.6K 
SPL
All quiet on the Starpharma forum
28/04/25 4 841
Industrials SECTOR NEWS

Long-Term Exclusive $35 Million Supply Agreement Signed

3DA
29 Apr 2025
AMAERO LTD
28/04/25 Last post  Joelsmith2452 Comments Created with Sketch.  4  Views Created with Sketch.  841 
SPL
Pharmaceuticals in tariff crises
27/04/25 9 1.7K
27/04/25 Last post  Starlink Comments Created with Sketch.  9  Views Created with Sketch.  1.7K 
SPL
Morningstar valuation downgrade
24/04/25 54 17K
24/04/25 Last post  sarge17 Comments Created with Sketch.  54  Views Created with Sketch.  17K 
SPL
DEP SN-38 and Starpharma moving forward
23/04/25 3 1.2K
23/04/25 Last post  jwoody1000 Comments Created with Sketch.  3  Views Created with Sketch.  1.2K 
SPL
DEP Radiopharmaceuticals AGM error
21/04/25 2 1.2K
21/04/25 Last post  sarge17 Comments Created with Sketch.  2  Views Created with Sketch.  1.2K 
SPL
Starpharma, Sanofi Avantis's Jevtana®, Roche’s Kadcyla® and a 3 billion dollar business
17/04/25 26 9.8K
17/04/25 Last post  thrasher Comments Created with Sketch.  26  Views Created with Sketch.  9.8K 

See All Discussions arrow Created with Sketch.

Timeline

Notification of cessation of securities - SPL
04 Apr 10:05
 
Application for quotation of securities - SPL
04 Apr 10:02
 
Becoming a substantial holder
17 Mar 16:12
 
Half Yearly Report and Accounts
26 Feb 09:44
 
Quarterly Activities/Appendix 4C Cash Flow Report
29 Jan 10:16
 
DEP Presentation at Targeted Radio Therapies Conference
16 Jan 14:58
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
9.4¢
Change
0.000(0.00%)
Mkt cap ! $39.31M
Open High Low Value Volume
9.4¢ 9.4¢ 9.3¢ $15.67K 167.1K

Buyers (Bids)

No. Vol. Price($)
1 109890 9.1¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 131789 4
View Market Depth
Last trade - 16.10pm 29/04/2025 (20 minute delay) ?
Last
9.3¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
9.3¢ 9.4¢ 9.2¢ 124849
Last updated 15.58pm 29/04/2025 ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.